Answers are grounded in this paper and cite their sources.
Advancements in sensor technologies capable of measuring key biomarkers can greatly enhance medical diagnostics and health monitoring, facilitating more effective diagnosis, treatment, and prevention. While there are numerous biomarkers of interest, gaseous ammonia (NH 3 ) stands out due to its significance as an indicator of organ function (e.g., liver and kidney failure) or bacterial infections (e.g., Helicobacter pylori , Proteus mirabilis ) in the body. This review discusses the metabolism and presence of NH 3 in body organs, as well as clinical conditions associated with the regulation of NH 3 concentrations. This paper reviews various sensing materials and parameters, along with current state‐of‐the‐art gas sensors capable of detecting NH 3 for biomedical applications. Additionally, it addresses the challenges faced by biomedical sensing technologies already in use in medical applications. This review highlights that while NH 3 sensing applications for breath analysis are already well‐developed, in vivo NH 3 sensing remains in its early stages and faces significant challenges. Finally, promising future research directions for NH 3 sensing are discussed, including the integration of NH 3 sensors in catheters or in the Simulator of Human Intestinal Microbial Ecosystem, as well as the early detection of antibiotic‐resistant bacteria to enhance medical diagnostics.
No takes yet. Share an insight, caveat, or question.
Nijkoops et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: